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Abstracts
Background: The carcinogenesis of colorectal cancer has been accepted by a model for a cascade
of genetic alterations, named the adenoma-carcinoma sequence. In order to elucidate the
carcinogenesis of the colorectal cancer more clearly, the genetic abnormalies of the non-neoplastic
mucosal epithelium of the colon and rectum should be investigated. It has been speculated that
colonic Paneth cell metaplasia (PaM) is one of the pre-neoplastic mucosa of colonic cancer.
Therefore, we studied the propria mucosa of the right colon with PaM from the standpoints of the
frequency of the K-ras codon 12 mutations (K-ras), which is initial genetic abnormality in colorectal
cancer, and the loss of heterozygosity of microsatellite markers (LOH-MS), which has a relationship
to development of colorectal cancer.
Methods: Fifty-two regions with PaM histopathologically from 12 surgically resected right colon
specimens were studied. DNA extraction of the colonic mucosa with PaM was obtained using a
microdissection method, and the frequency of the K-ras of PaM was investigated by enriched
polymerase chain reaction-enzyme linked mini-sequence assay, and the frequency of the LOH-MS
(D2S123, D17S250 and D5S346) of PaM was examined by high resolution fluorescenced labeled
PCR primers.
Results: K-ras mutation was detected in fifteen regions among 52 PaM (28.9%). All mutations were
a single mutation and GGT changed to AGT in eleven and GAT in four. LOH-MS were detected in
twenty-one regions among 52 PaM (40.4%) (D2S123: 35.4%, 17/48 regions, D17S250: 13.7%, 7/51
regions, and D5S346: 0%, 0/52 regions). No K-ras mutations and LOH-MS were detected in the
controls (Colorectal mucosa with no PaM).
Conclusions: Colonic mucosa with Paneth cell metaplasia may be one of the pre-neoplastic
mucosa in the development of the colonic epithelial neoplasia.
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Background
Vogelstein et al. [1] have reported the involvement of
multistage genetic abnormalities in the development of
colorectal cancers, and pointed out that K-ras mutation is
the initial genetic abnormality in the adenoma-carcinoma
sequence [2] of the development of the colorectal cancer.
Recently, some reports have pointed out that the replica-
tion errors and loss of heterozygosity of the microsatellite
markers have the development of the colorectal cancer
[3,4].
However, the genetic abnormalities of the non-neoplastic
mucosal epithelium of the colon and rectum has not been
investigated, except the aberrant crypt foci [5] and hyper-
plastic polyp [6], although the colorectal epithelial neo-
plasia is derived from the colorectal mucosal epithelium.
For the preventive medicine, the genetic abnormalities of
the pre-neoplastic mucosa of the colorectal cancer should
be known.
We have speculated previously that the colorectal Paneth
cell metaplasia (PaM) is one of pre-neoplastic mucosa on
the development of the colorectal epithelial neoplasias
[7], because PaM were seen very frequently in the adjacent
mucosa to the minute-sized colorectal epithelial neopla-
sias as well as within these neoplasias.
The main purpose of the present study was to investigate
the frequencies of the K-ras codon 12 mutations (K-ras)
and the loss of heterozygosity of dinucleotide microsatel-
lite markers (LOH-MS) in the propria mucosa with PaM
of the right colon.
Methods
The materials were 12 surgically resected specimens of
right colon, which had the colonic carcinomas were
present, and histological diagnosis was assessed at the
Department of Pathology, Juntendo Izunagaoka Hospital.
Although we have intended to investigate the PaM in the
normal colon of the individuals without cancer, using the
biopsies specimens, it was difficult to detect the PaM in
these specimens. No inflammatory bowel diseases were
included in the materials. Informed consent was obtained
from all the patients to investigate the genetic alterations
in the current study.
The specimens were fixed in 10 % buffered formalin solu-
tion and prepared by cutting the non-neoplasitic area into
3 – 5 mm sections. Each section was embedded in paraffin
and stained with hematoxylin and eosin (HE), followed
by immunohistochemical staining for anti-lysozyme
(DAKO, Japan). Immunohistochemical stainings were
performed by the avidin-biotin-peroxidase-complex
method, at dilution of 1 : 100.
Fifty-two colonic mucosal regions with PaM, distant from
neoplastic lesion, aberrant crypt foci and hyperplastic
polyp, were detected by HE staining and anti-lysozyme
antibody staining, and these mucosa were used as the tar-
get regions in the current study.
All paraffin blocks of the target regions and 12 paraffin
blocks with no PaM as controls of each materials were
used for the DNA extraction.
DNA extraction
Paraffin blocks with the target foci mentioned above were
prepared for DNA extraction. The target foci were micro-
dissected using a 20-gauge needle, comparing the slide
with HE staining in the same position. The extracted DNA
was diluted with 5 ml of TaKaRa DEXPAT (for DNA
Extraction from Paraffin-embedded Tissue, TaKaRa Bio-
medical Inc.).
Analysis of the K-ras
Mutation of K-ras was analyzed and compared by
enriched polymerase chain reaction-enzyme linked mini-
sequence assay (PCR-ELMA). In PCR-ELMA [8,9],
upstream primer for the first and second PCR was 5'-
TAAACTTGTGGTAGTTGG-AACT-3', downstream primer
for the first PCR was 5'-GTTGGATCA-TATTCGTC-CAC-3',
and downstream for primer the second PCR was 5'-
CAAATGAT-CTGA-ATTAGCTG-3'. The first PCR reaction
was performed containing 1 µL of DNA lysate, 100 µM
dNTP, 1.5 mM MgCl2, 1 µM each primer, 0.625 U Taq
DNA polymerase and 1 × PCR buffer [containing 10 mM
Tris-HCl(pH 8.3 at 25 degrees of temperature), 50 mM
KCl and 0.001%(w/v) gelatin] in a thermal cycler. Then,
10 µL of the denatured second PCR product was hybrid-
ized with probes to detect the K-ras codon 12 wild-type
(GGT) and six mutant (GAT, GCT, GTT, AGT, CGT and
TGT) DNAs were immobilized, at 55 degrees of tempera-
ture for 30 minutes, and 100 µL of biotinylated A and 0.01
U of TdqDNA polypmerase were added and incubation
was continued at 55 degrees of temperature for 30
minutes.
For development, 100 µL of avidin-horseradish peroxi-
dase conjugate was added and the reaction was performed
at room temperature for 30 minutes. Then, 100 µL of
tetramethyl-benzidine (TMB) substrate was added and the
plates were left to develop in the dark at room tempera-
ture for 20 minutes. Finally, 100 µL of stop solution was
contained and the light absorbance of each sample was
measured by spectrophotometry (Multiskan Multisoft,
Labsystems, Tokyo) with a 450 nm filter wavelength (Fig-
ure 1).Journal of Carcinogenesis 2005, 4:5 http://www.carcinogenesis.com/content/4/1/5
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Analysis of the LOH-MS
Although we have intended to investigate the frequency of
microsatellite instabilities using five microsatellite mark-
ers, which has been recommended by National Cancer
Institute[10], the replication error or microsatellite insta-
bilities could not be detected. Although the true reasons
for these failures was not know, we may think that the tar-
get foci were too small and post-formalin solution condi-
tion with long time.
Therefore, only LOH was investigated described below.
Three dinucleotide microsatellite markers (D2S123,
D17S250 and D5S346) were selected for LOH among the
microsatellite markers, recommended by National Cancer
Institute, because commonly it has been thought to be dif-
ficult to study the LOH using mononucleotide microsatel-
lite markers.
These LOH-MS were investigated using high resolution
fluorescenced labeled PCR primers in proportion to the
method of Tsuchida et al. [11]. The outline of it : 1. PCR
was performed containing 1 µL of DNA lysate, 100 µM
dNTP, 1.5 mM MgCl2, 1 µM each primer marked with flu-
orescent dye of three colors as blue, green and yellow,
0.625 U Taq DNA polymerase and 1 × PCR buffer [con-
taining 10 mM Tris-HCl(pH 8.3 at 25°C), 50 mM KCl and
0.001%(w/v) gelatin] in a thermal cycler. 2. The electro-
phoresis was conducted 2 hours by means of an ABI-377
DNA auto-sequencer (PE Biosystems, Inc., Foster City, CA,
USA). 3. A comparison was made of peaks of same marker
arising from normal tissue and the propria mucosa with
PaM, using the Gene Scan TM waveform analyzed soft-
wave, and LOH were assessed. That is to say, LOH (+) was
assessed when the ratio of the peak area of (the propria
mucosa with PaM/normal tissue) was less than 70 % or
was more than 143 %.
The data were analyzed statistically with Student's t-test (t-
test) and chi-square test ; a p-value of less than 0.05 was
considered to be significant.
Results (Table 1)
K-ras mutation was detected in fifteen regions among 52
PaM (28.9 %). All mutations were a single mutation. For
K-ras mutation patterns, 11 showed GGT to AGT, and four
showed to GAT.
LOH-MS was detected in twenty-one regions among 52
PaM (40.4 %) (D2S123: 35.4 %, 17/48 regions, D17S250:
13.7 %, 7/51 regions, and D5S346: 0 %, 0/52 regions).
No K-ras mutations and LOH-MS were detected in the
controls (Colorectal mucosa with no PaM, no neoplastic
lesion, no aberrant crypt foci and no hyperplastic polyp).
Thus, the frequency of both K-ras mutation and LOH-MS
in the colonic mucosa with PaM were significantly higher
than those of the controls (p < 0.01, chi-square test).
Discussion
K-ras mutations have been detected in several human neo-
plasias [12-14], and it has been pointed out that K-ras
mutation is the initial genetic abnormality in the develop-
ment of the colorectal cancers [1]. Recently, the replica-
tion errors of the gene is thought to be important in the
development of the colorectal cancer. And the loss of het-
erozygosity of the microsatellite markers, which are often
used as the targets in the investigation for the replication
errors of the gene, is also considered to be important in
the development of the colorectal cancer [3,4]. Namely,
the carcinogenesis of colorectal cancer is almost clarified.
In order to conclude the carcinogenesis of the colorectal
cancer more clearly, the genetic abnormality of the non-
neoplastic mucosal epithelium of the colon and rectum
should be investigated, however, because the colorectal
cancers are derived from the colorectal mucosa. It is also
important for the preventive medicine of the colorectal
cancer to know the carcinogenesis of it.
Enriched polymerase chain reaction-enzyme linked mini- sequence assay (PCR-ELMA), showing K-ras codon 12 muta- tion in the colonic Paneth cell metaplasia Figure 1
Enriched polymerase chain reaction-enzyme linked mini-
sequence assay (PCR-ELMA), showing K-ras codon 12 muta-
tion in the colonic Paneth cell metaplasia. AGT-type muta-
tion was seen in line 3.Journal of Carcinogenesis 2005, 4:5 http://www.carcinogenesis.com/content/4/1/5
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However, until now, the genetic abnormalities of the
colorectal non-neoplastic mucosa is unclear, except the
aberrant crypt foci [5] and hyperplastic polyp [6].
We have already reported that the colorectal Paneth cell
metaplasia (PaM) is one of pre-neoplastic mucosa on the
development of the colorectal epithelial neoplasias [7],
because PaM were seen very frequently in the adjacent
mucosa to the minute-sized colorectal epithelial neopla-
sias and within these neoplasias.
Therefore, K-ras mutation and the loss of heterozygosity
of microsatellite markers of PaM were investigated in this
study, and the current study is thought to be the first
report focusing on this.
Our results showed that K-ras mutation was detected in
fifteen regions among 52 PaM (28.9%), and LOH-MS was
detected in twenty-one regions among 52 PaM (40.4%).
Namely, K-ras mutation and LOH-MS of PaM were not
rare and the frequency of those of PaM were higher than
those of the normal colonic mucosa, and it came to light
that some PaM had the genetic abnormalities which had
a relationship to the development of colorectal cancer.
Paneth cells, which are usually situated at the base of the
glands of the small intestine, were first identified by
Scwalbe [15] in 1872, were studied in detail morphologi-
cally by Paneth [16] in 1888.
Now, these cells have been one of the most famous cells
in the gastro-intestinal tract, however, the detail function
of these is not clear. Paneth cells are sometimes seen in the
colorectal tubules, for example in the proximal colonic
mucosa of elderly subjects [7,17], in patients with ulcera-
tive colitis [18] and colonic epithelial neoplasia [1,19,20],
although the reasons why Paneth cells appear in the large
bowel is still unknown.
Described above, many riddles about Paneth cell are still
remained. And the gene abnormalities of colonic mucosa
with PaM in the current study may be not equal to those
of single Paneth cell in the colonic mucosa, because it is
difficult to obtain only single Paneth cell in the colonic
mucosa, even if microdissection method is used.
However, we have been able to investigate the colonic
mucosa with PaM, and we think it very interesting that
some PaM have K-ras mutation and the loss of heterozy-
gosity of microsatellite markers, and these PaM may be
thought to be the pre-neoplastic mucosa in development
of the colonic epithelial neoplasia. Further molecular
studies concerning Paneth cell metaplasia in the large
bowel should be warranted.
Conclusions
Colonic mucosa with Paneth cell metaplasia may be one
of the pre-neoplastic mucosa in the development of the
colonic epithelial neoplasia.
Abbreviations
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